Robert Califf addressed a range of issues, including AI, lack of nutrition resources at the FDA and how he evaluates the progress of precision medicine at the Precision Medicine World Conference in Silicon Valley. The post “Precision Med Has Evolved as Badly As I Expected” And OtherTakeaways From Former FDA Commissioner At PMWC appeared first…
Novo Nordisk’s monlunabant showed signs of neuropsychiatric side effects in a mid-stage diabetic kidney disease study, despite a drug design intended to favor hitting its target receptor in peripheral tissues rather than the brain. Neuro effects were also reported last year in a Phase 2 test of this pill in obesity. The post Oral Metabolic…
UCSF’s Lisa Rotenstein, M.D., M.B.A., discusses a Health Affairs Commentary article about the relationship between physicians, advanced practice providers in primary care
It’s always fun to chat with Jonathan Bush. You kids today may not remember that he was the first CEO to take a cloud-based (Health 2.0!) company public back in 2007! Athenahealth didn’t end up challenging Epic because a cosmically evil hedge fund took it (and him) down as it was on its way to…
Little Otter’s $9.5 million fundraise included participation from Pivotal Ventures, Torch Capital, Springbank, CRV, Next Legacy, G9, Gratitude Railroad and Carrie Walton Penner’s Fiore Ventures. The company has raised more than $36 million to date. The post Little Otter Raises $9.5M for Family Mental Health appeared first on MedCity News.
Citing the hundreds of lives lost to extreme heat each year, California state housing officials are urging lawmakers to set residential cooling standards long opposed by landlords and builders who fear such a measure would force them to make big-ticket upgrades. In a 60-page report sent Monday to the legislature, the California Department of Housing…
It is imperative to understand the various regulatory variations globally, develop a strategy for new technologies, engage in harmonization activities, and implement risk management measures. The post Navigating Complex Regulatory Landscapes in the Biopharmaceutical Industry appeared first on MedCity News.
While new technologies may demonstrate clinical benefits in controlled settings, their true value is determined by how well they fit into existing healthcare workflows. The post Balancing Innovation and Risk in Healthtech appeared first on MedCity News.
Experian Health is very pleased to announce that we’ve ranked #1 in the 2025 Best in KLAS: Software & Services report, for our Contract Manager and Contract Analysis product, for the third consecutive year. Contract Manager, when paired with Contract Analysis, empowers healthcare providers by ensuring payers comply with contract terms, identifying and recovering underpayments, and arming them…
[Sponsored] In an interview, Redox CEO Trip Hofer shared why the company is well-positioned to facilitate the push for the nationwide exchange of electronic health information facilitated by the TEFCA framework. The post How Redox is Future-Proofing Healthcare Data as Interoperability Standards Evolve appeared first on MedCity News.